Big Data & Analytics

AI Tool Waldo Scans Social Media for Health Product Risks
Tech & Innovation AI Tool Waldo Scans Social Media for Health Product Risks

Imagine a world where a single social media post could trigger a safety alert for a widely used health supplement, saving countless consumers from potential harm. This scenario is no longer a distant dream but a tangible reality with the emergence of cutting-edge AI tools designed to monitor health

Automation Drives Clinical Labs into the Fifth Revolution
Tech & Innovation Automation Drives Clinical Labs into the Fifth Revolution

The clinical laboratory sector stands on the brink of a monumental shift, propelled by the relentless march of automation and sophisticated data management systems, transforming how diagnostics influence patient care. As healthcare navigates the transition from the Fourth Industrial Revolution

Can Biomarkers Revolutionize MASLD Diagnosis and Prognosis?
Tech & Innovation Can Biomarkers Revolutionize MASLD Diagnosis and Prognosis?

Unlocking MASLD: The Quest for Reliable Biomarkers Imagine a silent epidemic affecting millions globally, where a liver condition tied to metabolic dysfunction progresses undetected until it spirals into life-threatening outcomes like cancer. Metabolic dysfunction-associated steatotic liver disease

How Will AI Transform UK Healthcare by 2026?
Management & Regulatory How Will AI Transform UK Healthcare by 2026?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the integration of artificial intelligence in healthcare.

How Does Alnylam Boost Inclusive Drug Discovery with AGD?
Tech & Innovation How Does Alnylam Boost Inclusive Drug Discovery with AGD?

In an era where precision medicine is reshaping healthcare, a groundbreaking collaboration is setting a new standard for drug discovery with an emphasis on inclusivity. Alnylam Pharmaceuticals, a pioneer in RNA interference (RNAi) therapeutics, has joined forces with the Alliance for Genomic

AI to Decide Medicare Treatments in New Pilot Program
Tech & Innovation AI to Decide Medicare Treatments in New Pilot Program

Imagine a healthcare system where algorithms, alongside doctors, play a pivotal role in determining the fate of critical treatments for millions of seniors, marking a transformative shift in medical decision-making. This scenario is no longer speculative but a reality unfolding through a pioneering

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later